| Today's Open | $172.02 |
|---|---|
| Previous Close | $171.14 |
| Daily Range | $169.07 - $172.68 |
| 52-Week Range | $129.41 - $194.44 |
| Market Cap | $93.3B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | $2.26 (1.3%) |
| Ex-Dividend Date Dividend Pay Date |
03/21/13 04/02/13 |
| Volume | 323,164 |
| Average Daily Volume | 240,651 |
| Current FY EPS | $8.14 |
Sector
Healthcare
Industry
Drugs
Novo Nordisk (NVO) Description
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/
News & Commentary
Positive Data on Novo Nordisk's N9-GP - Analyst Blog
Positive Data on Novo Nordisk's N9-GP - Analyst BlogWill the FDA Approve Merck's Insomnia Drug?
The advisory committee meeting is this Wednesday, but investors will have to wait until the summer to discover the Food and Drug Administration's decision.What Does This Failure Mean for Eli Lilly Investors?
Eli Lilly announced that it will stop developing cancer drug candidate enzastaurin. What does this mean for its business?NVO's Top Competitors
(-0.93%)
(-0.15%)
(-0.01%)
(1.45%)